Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.

Saved in:
Bibliographic Details
Title: Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Authors: Michel LL; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ziegler P; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Kreis P; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Hartkopf AD; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Wallwiener M; Department of Gynecology, Halle University Hospital, Halle, Germany., Häberle L; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany., John N; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany., Kolberg HC; Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany., Hadji P; Frankfurt Center for Bone Health and Endocrinology, Frankfurt am Main, Germany., Tesch H; Oncology Practice, Bethanien Hospital, Frankfurt am Main, Germany., Ettl J; Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; Cancer Center Kempten/ Allgäu (CCKA), Klinikum Kempten, Kempten Germany., Lüftner D; Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Medical University of Brandenburg Theodor-Fontane, Rüdersdorf bei Berlin, Germany., Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany., Belleville E; ClinSol GmbH & Co KG, Würzburg, Germany., Wimberger P; National Center for Tumor Diseases Dresden and Department of Gynecology and Obstetrics, University Hospital Dresden, TU Dresden, Dresden, Germany., Enzinger HM; Klinik für Frauenheilkunde und Geburtshilfe, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany., Huebner H; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Uhrig S; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Hack CC; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Krabisch P; Klinikum Chemnitz gGmbH, Medizincampus Chemnitz der Technischen Universität Dresden, Dresden, Germany., Fasching PA; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany. Electronic address: peter.fasching@uk-erlangen.de., Wuerstlein R; Breast Center and CCC Munich, Dept of Gynecology and Obstetrics, University Hospital LMU Munich, Munich, Germany., Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany., Ditsch N; Gynecology, Obstetrics and Senology, Faculty of Medicine, University of Augsburg, Breast Center, University Hospital Augsburg, Augsburg, Germany; CCC WERA, Germany., Hein A; Department of Gynecology and Obstetrics, Klinikum Esslingen, Esslingen, Germany., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Taran FA; Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Medical Faculty and University Clinic of Cologne, University of Cologne, Cologne, Germany., Lux MP; Department of Gynecology and Obstetrics, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Germany; St. Vincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany., Wallwiener D; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Brucker SY; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Fehm TN; Department of Gynecology and Obstetrics, Düsseldorf University Hospital, Düsseldorf, Germany; Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Düsseldorf, Germany., Schneeweiss A; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany., Goossens C; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Engler T; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115689. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2025.115689